Compare REPL & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPL | FSBC |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2018 | 2021 |
| Metric | REPL | FSBC |
|---|---|---|
| Price | $12.37 | $43.86 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $5.67 | ★ $41.90 |
| AVG Volume (30 Days) | ★ 1.8M | 137.4K |
| Earning Date | 05-21-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.47% |
| EPS Growth | N/A | ★ 28.32 |
| EPS | N/A | ★ 1.78 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.25 |
| Revenue Next Year | N/A | $12.30 |
| P/E Ratio | ★ N/A | $24.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $30.68 |
| 52 Week High | $16.33 | $50.26 |
| Indicator | REPL | FSBC |
|---|---|---|
| Relative Strength Index (RSI) | 41.23 | 34.30 |
| Support Level | $12.40 | $39.93 |
| Resistance Level | $16.02 | $47.43 |
| Average True Range (ATR) | 0.73 | 0.97 |
| MACD | -0.22 | -0.21 |
| Stochastic Oscillator | 16.61 | 15.21 |
Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.
Five Star Bancorp is a bank holding company that operates in California through its subsidiary, a state-chartered non-member bank. The company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans, and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment: Banking.